Tailored DAPT: still a theory in search of proof.

No abstract is available for this paper.

• Publication year

  2025

• Venue

  European Heart Journal

• Publication date

  2025-08-31

• Fields of study

  Medicine

• Identifiers
  DOI 10.1093/eurheartj/ehaf649PMID 40886180
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Temporal modulation of antiplatelet therapy in high-risk patients undergoing complex percutaneous coronary intervention: the TAILORED-CHIP randomized clinical trial.

  2025cited by this paper
• Temporal modulation (early escalation and late de-escalation) of antiplatelet therapy in patients undergoing complex high-risk PCI: rationale and design of the TAILORED-CHIP trial.

  2024cited by this paper
• 2024 ESC Guidelines for the management of chronic coronary syndromes.

  2024cited by this paper
• Aspirin-free antiplatelet strategies after percutaneous coronary interventions.

  2024cited by this paper
• Timing, Selection, Modulation, and Duration of P2Y12 Inhibitors for Patients With Acute Coronary Syndromes Undergoing PCI.

  2023cited by this paper
• Personalised antiplatelet therapies for coronary artery disease: what the future holds.

  2023cited by this paper
• Defining Strategies of Modulation of Antiplatelet Therapy in Patients With Coronary Artery Disease: A Consensus Document from the Academic Research Consortium

  2023cited by this paper
• 1-Month Dual-Antiplatelet Therapy Followed by Aspirin Monotherapy After Polymer-Free Drug-Coated Stent Implantation: 1-Month DAPT Trial.

  2021cited by this paper
• Guided versus standard antiplatelet therapy in patients undergoing percutaneous coronary intervention: a systematic review and meta-analysis.

  2021cited by this paper
• Ticagrelor versus clopidogrel in elective percutaneous coronary intervention (ALPHEUS): a randomised, open-label, phase 3b trial.

  2020cited by this paper
• Trial Design Principles for Patients at High Bleeding Risk Undergoing PCI: JACC Scientific Expert Panel.

  2020cited by this paper
• Defining High Bleeding Risk in Patients Undergoing Percutaneous Coronary Intervention

  2019cited by this paper
• Dual Antiplatelet Therapy Duration Based on Ischemic and Bleeding Risks After Coronary Stenting.

  2019cited by this paper
• Derivation and validation of the predicting bleeding complications in patients undergoing stent implantation and subsequent dual antiplatelet therapy (PRECISE-DAPT) score: a pooled analysis of individual-patient datasets from clinical trials.

  2017cited by this paper
• Efficacy and Safety of Dual Antiplatelet Therapy After Complex PCI.

  2016cited by this paper

• No citing papers are available for this paper.